Xenpozyme: a revelation for Neiman-Pick disease
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20232067Keywords:
Xenpozyme, Neiman-Pick disease, Acid sphingomyelinase deficiencyAbstract
Nieman-Pick disease (NPD) also known as acid sphingomyelinase deficiency (ASMD) is a rare autosomal recessive disorder of lysosomal storage which affects 1 in 250,000 individuals mainly belonging to the Ashkenazi Jew population. The prevalence varies across the three main subtypes where type A and B affects 1 in 40,000 and type C affects 1 in 150,000 individuals, being more prevalent in the French-Acadian descent in the region of Nova Scotia.
Metrics
References
Bianconi SE, Hammond DI, Farhat NY, Dang Do A, Jenkins K, Cougnoux A, et al. Evaluation of Age of Death in Niemann-Pick Disease, type C: Utility of Disease Support Group Websites to Understand Natural History. Mol Genet Metab. 2019;126(4):466-9.
Thurm A, Chlebowski C, Joseph L, Farmer C, Adedipe D, Weiss M, et al. Neurodevelopmental Characterization of Young Children Diagnosed with Niemann-Pick Disease, Type c1. J Dev Behav Pediatr. 2020;41(5):388-96.
Nafeesuddin MM, Mustafa MS, Mussarat A, Azam ST, Siddiq MA. Xenpozyme: The First Spellbound Therapy. IJS Global Health. 2023;6(2):e122.
Bajwa H, Azhar W. Niemann-Pick Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
Santos-Lozano A, Villamandos García D, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, et al. Niemann-Pick Disease Treatment: A Systematic Review of Clinical Trials. Ann Transl Med. 2015;3(22):360.
Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Gallagher RC, et al. A randomized, Placebo-Controlled Clinical Trial Evaluating Olipudase Alfa Enzyme Replacement Therapy For Chronic Acid Sphingomyelinase Deficiency (ASMD) in Adults: One-year Results. Genet Med. 2022;24(7):1425-36.
Diaz GA, Jones SA, Scarpa M, Mengel KE, Giugliani R, Guffon N, et al. One-year Results of A Clinical Trial of Olipudase Alfa Enzyme Replacement Therapy in Pediatric Patients with Acid Sphingomyelinase Deficiency. Genet Med. 2021;23(8):1543-50.